CH240102A - Process for the preparation of a lactone of the cyclopentanopolyhydrophenanthrene series. - Google Patents

Process for the preparation of a lactone of the cyclopentanopolyhydrophenanthrene series.

Info

Publication number
CH240102A
CH240102A CH240102DA CH240102A CH 240102 A CH240102 A CH 240102A CH 240102D A CH240102D A CH 240102DA CH 240102 A CH240102 A CH 240102A
Authority
CH
Switzerland
Prior art keywords
lactone
allo
ester
preparation
acid
Prior art date
Application number
Other languages
German (de)
Inventor
Aktiengesellschaft Ciba
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of CH240102A publication Critical patent/CH240102A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J19/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

      Verfahren    zur     Herstellung    eines     Lactons    der     Cyclopentanopolyhydrophenanthren-Reihe.       Gegenstand des vorliegenden Patentes ist ein  Verfahren zur Herstellung eines     Lactons    der       Cyclopentanopolyhydrophenanthren    - Reihe,  welches dadurch gekennzeichnet ist, dass man  ein     3,21-Diacyloxy-allopregnan-20-on,    das       konfigurativ    dem     epi-Cholestanol    entspricht,  mit einem     Halogenessigsäureester    kondensiert  und auf das Reaktionsprodukt wasserabspal  tende und verseifende Mittel einwirken lässt.  



  Die so erhaltene neue Verbindung, das  d     '0,'--3,21    -     Dioxy-nor-allo-cholensäure-lacton,     schmilzt bei     24ä-244 .    Sie soll therapeu  tische Verwendung finden oder als Zwischen  produkt zur Herstellung therapeutisch ver  wendbarer Verbindungen dienen.  



  <I>Beispiel:</I>  600 mg 3,21-     Diacetoxy    -     allo    -     pregnan-          20-on    vom F. 156 , das     konfigurativ    dem     epi-          Cholestanol    entspricht (erhalten aus     3-Acet-          oxy-allo-ätio-cholansäure-methylester    durch  Überführung in an sich bekannter Weise  über das     17-Säurechlorid    zum     3-Acetoxy-17-          diazoketon    sowie anschliessende Behandlung    mit Eisessig),

   werden in 5     cm@    absolutem  Benzol gelöst und     mit    300 mg Bromessig  ester und 120 mg Zink in     Reaktion    gebracht.  Man erwärmt 2 Stunden auf dem Wasser  bade, zersetzt dann mit Eis und verdünnter  Salzsäure und nimmt das Reaktionsprodukt  in Äther auf. Die Ätherlösung wird mit  Wasser und verdünnter     Bicarbonatlösüng     ausgewaschen, über wasserfreiem Natrium  sulfat getrocknet und eingedampft.

   Der  Rückstand wird zwecks     Wasserabspaltung     mit     Acetanhydrid    gekocht,     wobei    das 4     2o,22-3-          Acetoxy    -21-     oxy    -     nor    -     allo-        cholensäur        e-lacton     vom F. 230  erhalten wird. Es lässt sich  durch saure     Verseifung    in das     42@@    2-3,21  Dioxy-nor-allo-cholensäure-lacton vom F. 243  bis 244  umwandeln.



      Process for the preparation of a lactone of the cyclopentanopolyhydrophenanthrene series. The subject of the present patent is a process for the production of a lactone of the cyclopentanopolyhydrophenanthrene series, which is characterized in that a 3,21-diacyloxy-allopregnan-20-one, which corresponds configuratively to the epi-cholestanol, is condensed with a haloacetic acid ester and on the reaction product allows dehydrating and saponifying agents to act.



  The new compound obtained in this way, the d '0,' - 3,21 - dioxy-nor-allo-cholenic acid-lactone, melts at 24-244. It should find therapeutic use or serve as an intermediate product for the preparation of therapeutically ver usable compounds.



  <I> Example: </I> 600 mg 3.21-diacetoxy-allo-pregnan-20-one from F. 156, which corresponds configuratively to epi-cholestanol (obtained from 3-acetoxy-allo-etio-cholanic acid methyl ester by conversion in a manner known per se via the 17-acid chloride to 3-acetoxy-17-diazoketone and subsequent treatment with glacial acetic acid),

   are dissolved in 5 cm @ absolute benzene and reacted with 300 mg of bromoacetic ester and 120 mg of zinc. It is heated for 2 hours, bathed in water, then decomposed with ice and dilute hydrochloric acid and the reaction product is taken up in ether. The ethereal solution is washed out with water and dilute bicarbonate solution, dried over anhydrous sodium sulfate and evaporated.

   The residue is boiled with acetic anhydride for the purpose of splitting off water, the 4 2o, 22-3-acetoxy-21-oxy-nor-allo- cholenic acid e-lactone having a melting point of 230 being obtained. It can be converted into the 42 @@ 2-3,21 dioxy-nor-allo-cholenic acid-lactone from F. 243 to 244 by acidic saponification.

 

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung eines Lactons der Cyclopentanopolyhydrophenanthren - Reihe, dadurch gekennzeichnet, dass man ein 3,21- Diacyloxy-allo-pregnan-20-on, das konfigu- rativ dem epi-Cholestanol entspricht, mit einem Halogenessigsäureester kondensiert und auf das Reaktionsprodukt wasserabspal tende und verseifende Mittel einwirken lässt. PATENT CLAIM: A process for the production of a lactone of the cyclopentanopolyhydrophenanthrene series, characterized in that a 3,21-diacyloxy-allo-pregnan-20-one, which corresponds to the configuration of epi-cholestanol, is condensed with a haloacetic acid ester and onto the reaction product lets water-releasing and saponifying agents act. Die so erhaltene neue Verbindung, das 420,2z-3 gl-Dioxy-nor-allo-cholensäure-lacton, schmilzt bei 243-244 . Sie soll therapeu tische Verwendung finden oder als Zwischen- Produkt zur Herstellung therapeutisch ver- ,vendbarer Verbindungen dienen. UNTERANSPRUCH: Verfahren nach Patentanspruch, dadurch gekennzeichnet, dass man Bromessigester als Halogenessigsäureester verwendet. The new compound obtained in this way, 420,2z-3 gl-dioxy-nor-allo-cholenic acid-lactone, melts at 243-244. It should find therapeutic use or serve as an intermediate product for the production of therapeutically usable compounds. SUBCLAIM: Process according to claim, characterized in that bromoacetic ester is used as the haloacetic ester.
CH240102D 1938-09-15 1938-09-15 Process for the preparation of a lactone of the cyclopentanopolyhydrophenanthrene series. CH240102A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH240102T 1938-09-15
CH234780T 1938-09-15

Publications (1)

Publication Number Publication Date
CH240102A true CH240102A (en) 1945-11-30

Family

ID=25727939

Family Applications (1)

Application Number Title Priority Date Filing Date
CH240102D CH240102A (en) 1938-09-15 1938-09-15 Process for the preparation of a lactone of the cyclopentanopolyhydrophenanthrene series.

Country Status (1)

Country Link
CH (1) CH240102A (en)

Similar Documents

Publication Publication Date Title
CH240102A (en) Process for the preparation of a lactone of the cyclopentanopolyhydrophenanthrene series.
CH242987A (en) Process for the preparation of a lactone of the cyclopentanopolyhydrophenanthrene series.
CH240103A (en) Process for the preparation of a lactone of the cyclopentanopolyhydrophenanthrene series.
CH250806A (en) Process for the preparation of a new oxyhydrophenanthrene derivative.
CH240098A (en) Process for the preparation of a lactone of the cyclopentanopolyhydrophenanthrene series.
DE845347C (en) Process for the preparation of pyridine-mercury compounds
CH240099A (en) Process for the preparation of a lactone of the cyclopentanopolyhydrophenanthrene series.
DE493482C (en) Process for the preparation of p-menthol-3
AT166702B (en) Process for the preparation of new halogenated pyrimidyl mercaptocarboxylic acids and their derivatives
CH242274A (en) Process for the preparation of a lactone of the cyclopentanopolyhydrophenanthrene series.
CH262555A (en) Process for the production of a-halo-y-lactones from a, y-dihalo-fatty acids.
CH235916A (en) Process for the hydration of an acetylene derivative of the cyclopentanopolyhydrophenanthrene series.
CH296485A (en) Process for the preparation of a new thiophene compound.
CH260994A (en) Process for the production of vitamin A acid.
CH240101A (en) Process for the preparation of a lactone of the cyclopentanopolyhydrophenanthrene series.
CH245879A (en) Process for the preparation of a new oxyhydrophenanthrene derivative.
CH240100A (en) Process for the preparation of a lactone of the cyclopentanopolyhydrophenanthrene series.
CH249115A (en) Process for the preparation of a new oxyhydrophenanthrene carboxylic acid derivative.
CH286364A (en) Process for the preparation of an oestrone isomer.
CH250808A (en) Process for the preparation of a new oxyhydrophenanthrene derivative.
CH230840A (en) Method of preparing a compound of the etiocholanic acid series.
CH258190A (en) Process for the preparation of a new oxyhydrophenanthrene derivative.
CH242989A (en) Process for the production of a lactone.
CH258187A (en) Process for the preparation of a new oxyhydrophenanthrene derivative.
DE1153362B (en) Process for the preparation of cyclododecanecarboxylic acid